Delivery Order SPE2DB24D2205-SPE2DB25FEFFL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $31,987.71. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating that AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count) valued at $21,325.14. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and the place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tagrisso 80 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $10,662.57. The order is scheduled for completion by September 2, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57. This firm fixed price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units. This Firm Fixed Price delivery order carries a ceiling value of $10,662.57 and is scheduled for completion by August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates...
- This delivery order, awarded on August 7, 2025, to AmerisourceBergen Drug Corp represents a $10,662.57 firm fixed-price contract for the supply of Tagrisso 80 mg tablets (30-count units) to the Defense Logistics Agency (DLA), a Defense Department component. The contract is competitively awarded with no set-aside designation and carries an ultimate completion date of August 28, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $10,662.57. The contract, which carries no set-aside designation, is a competitively awarded delivery order with an ultimate completion date of August 18, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This competitive award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance of this contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a...
- The Defense Logistics Agency (DLA) awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication used in cancer treatment. The contract, awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Tagrisso 80 mg tablets, with an ultimate completion date of August 29, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999.9 billion ceiling value and extends through December 2026. The contract involves no set-aside...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFFLDelivery Order
This delivery order, awarded July 22, 2025, to AmerisourceBergen Drug Corp for $21,325.14, provides 30-count bottles of Tagrisso 80 mg tablets to support federal healthcare needs. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and is being funded by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics arm. The award was made through open competition with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal procurement standards. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle serves as a comprehensive pharmaceutical support mechanism for military healthcare programs worldwide, enabling the delivery of an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contract activity demonstrates its role as a critical pharmaceutical distributor supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to address evolving medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 7/22/25 |